<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04901247</url>
  </required_header>
  <id_info>
    <org_study_id>2103-ABU-003-IK</org_study_id>
    <nct_id>NCT04901247</nct_id>
  </id_info>
  <brief_title>A Time-lapse Monitoring Prospective Study</brief_title>
  <official_title>Exploring Single Step Culture Medium Refreshment Effect on Embryo Ploidy Rate: A Time-lapse Monitoring Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ART Fertility Clinics LLC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ART Fertility Clinics LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      While numerous types of commercially available human embryo culture media exist for human&#xD;
      blastocyst culture, the impact of culture conditions on blastocyst development and aneuploidy&#xD;
      formation is not fully understood. Culture conditions are very important for the success of&#xD;
      the in vitro fertilization (IVF) cycle, many of the factors involved in the process have been&#xD;
      extensively studied. However, none of the studies investigated the effect on euploid rate in&#xD;
      a sibling oocyte design with preimplantation genetic testing for aneuploidy (PGT-A), which&#xD;
      requires culture till day 7. In addition, the clinical outcome (implantation) will be&#xD;
      investigated in a frozen cycle regimen. Hence, the study will explore which day of media&#xD;
      refreshment will result in higher rate of ploidy and would improve clinical outcomes.&#xD;
      Investigators aim at exploring the best practice, that would empower the euploid rate through&#xD;
      the comparison of refreshing the single-step medium on day 3 or day 5 in a sibling oocyte&#xD;
      prospective design.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of extended embryo culture to the blastocyst stage and PGT-A has enabled&#xD;
      identification and selection of embryos with the best developmental potential and improved&#xD;
      IVF clinical outcomes. It is considered a routine practice to grade the embryos on day 3 of&#xD;
      development, which will require disturbing the culture conditions by annotating the embryos&#xD;
      using inverted microscopes. However, the application of Time-lapse technology (TLS) allows&#xD;
      annotating the embryos on day 3 without interrupting the culture conditions, especially if&#xD;
      TLS is combined with single-step culture medium.&#xD;
&#xD;
      There are several culture factors that can affect embryo development, such as the pH, which&#xD;
      is controlled through the concentration of CO2, and also the osmolality, which is the&#xD;
      concentration of solute per liter of solution. Evaporation of the solution due to the&#xD;
      exposure to high temperature (37°C) can change the concentrations and hence compromise embryo&#xD;
      development.&#xD;
&#xD;
      Since single-step medium is designed to sustain embryo development for 5 continuous culture&#xD;
      days, while some laboratories culture embryos for 7 days, refreshing the culture medium is&#xD;
      inevitable either on day 3 or day 5 of development.&#xD;
&#xD;
      There is no concrete evidence on which of these practices will provide a better environment&#xD;
      for embryo development. Moreover, none of the studies investigated the effect of single-step&#xD;
      culture medium changeover on day 3 or day 5, on the chromosomal errors (aneuploidy). We aim&#xD;
      in this study to explore which day of culture medium refreshment (day 3 or day 5) provides a&#xD;
      higher rate of euploid blastocysts.&#xD;
&#xD;
      Summary about data collected. Categorical data will be presented in frequency tables and&#xD;
      histograms. Continuous values will be summarized according the mean, standard deviation and&#xD;
      confidence interval.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 6, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>7 Days</target_duration>
  <primary_outcome>
    <measure>blastocyst ploidy</measure>
    <time_frame>3 days</time_frame>
    <description>determined after biopsy of trophectoderm cells, taken from the blastocyst on day 5, 6 or 7 from development.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cycle ploidy rate</measure>
    <time_frame>1 day</time_frame>
    <description>the number of euploid embryos in the group divided by the total number of 2PN</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mosaicism frequency</measure>
    <time_frame>1 day</time_frame>
    <description>defined as the rate of mosaic errors in aneuploid embryos. This includes full mosaic embryos or aneuploid embryos with 1 or more mosaic chromosome aberration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blastocyst quality at time of biopsy</measure>
    <time_frame>1 day</time_frame>
    <description>Four Embryo Quality Scores (EQ1, 2, 3, 4) based on the expansion stage of the blastocyst, the grade of the inner cell mass and the grade of the trophectoderm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blastulation rate</measure>
    <time_frame>5 days</time_frame>
    <description>ability of the embryo to form a cavity (=to blastulate) 118hours post ICSI. Number of blastocysts divided by the number of 2PN</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Aneuploidy</condition>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>day 3</arm_group_label>
    <description>embryo grading and culture refreshment will be done 67-69 hours post insemination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>day 5</arm_group_label>
    <description>embryo grading and culture medium refreshment will be done 114-118 hours post insemination</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>media refreshment</intervention_name>
    <description>20µL of culture medium is aspirated using Eppendorf PCR tips, and freshly, overnight equilibrated 20µL global total LP will be added to the same well</description>
    <arm_group_label>day 3</arm_group_label>
    <arm_group_label>day 5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>embryo grading</intervention_name>
    <description>embryo grading should be done prior to media refreshment</description>
    <arm_group_label>day 3</arm_group_label>
    <arm_group_label>day 5</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing a fertility treatment due to primary or secondary infertility at ART&#xD;
        Fertility Clinics.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a minimum of 8 - 10 follicles during ovarian stimulation&#xD;
&#xD;
          -  Patients with a minimum of 8 mature oocytes&#xD;
&#xD;
          -  PGT-A&#xD;
&#xD;
          -  ICSI&#xD;
&#xD;
          -  BMI&lt;35&#xD;
&#xD;
          -  Age 18- 40&#xD;
&#xD;
          -  Fresh or frozen ejaculatory sperm &gt;10,000 motile sperm&#xD;
&#xD;
          -  Any Ovarian stimulation&#xD;
&#xD;
          -  Embryos cultured in Time-lapse system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  PGT-M or PGT-SR&#xD;
&#xD;
          -  Previous history of embryo arrest&#xD;
&#xD;
          -  Endometriosis&#xD;
&#xD;
          -  Hydrosalpinx&#xD;
&#xD;
          -  History of uterine abnormality or previous uterine surgery&#xD;
&#xD;
          -  History of previous treatment which may impact the ovarian reserve (adnexal surgery,&#xD;
             chemotherapy, radiation…)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>IBRAHIM ELKHATIB</last_name>
    <role>Principal Investigator</role>
    <affiliation>ART Fertility Clinics LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BARBARA LAWRENZ, PhD</last_name>
    <phone>97126528000</phone>
    <phone_ext>1108</phone_ext>
    <email>shieryl.digma@artfertilityclinics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>SHIERYL DIGMA, RN</last_name>
    <phone>97126528000</phone>
    <phone_ext>1061</phone_ext>
    <email>shieryl.digma@artfertilityclinics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ART Fertility Clinics</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neelke De Munck, PhD</last_name>
      <phone>+971501982760</phone>
      <email>Neelke.demunck@artfertilityclinics.com</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Lawrenz, PhD, MD</last_name>
      <phone>+971526500757</phone>
      <email>Barbara.Lawrenz@artfertilityclinics.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ibrahim Elkhatib</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ibrahim Elkhatib, MSc</last_name>
      <email>ibrahimelkhatib@artfertilityclinics.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <link>
    <url>https://www.fertstert.org/article/S0015-0282(10)01712-7/fulltext</url>
    <description>Water evaporation and osmolarity change of human embryo culture media in humid or in dry culture systems</description>
  </link>
  <reference>
    <citation>Bavister BD, Poole KA. Duration and temperature of culture medium equilibration affect frequency of blastocyst development. Reprod Biomed Online. 2005 Jan;10(1):124-9.</citation>
    <PMID>15705308</PMID>
  </reference>
  <reference>
    <citation>Costa-Borges N, Bellés M, Meseguer M, Galliano D, Ballesteros A, Calderón G. Blastocyst development in single medium with or without renewal on day 3: a prospective cohort study on sibling donor oocytes in a time-lapse incubator. Fertil Steril. 2016 Mar;105(3):707-713. doi: 10.1016/j.fertnstert.2015.11.038. Epub 2015 Dec 12.</citation>
    <PMID>26690010</PMID>
  </reference>
  <reference>
    <citation>Krasnopolskaya KV, Beketova AN, Sesina NI, Сhinchenko NK, Badalyan GV, Sudarikova NM, Bocharova TV, Zakharchenko EO. The effect of short-term disturbance of day 3 embryo culture on the development and implantation. Gynecol Endocrinol. 2019;35(sup1):1-4. doi: 10.1080/09513590.2019.1632083.</citation>
    <PMID>31532309</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>May 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ART Fertility Clinics LLC</investigator_affiliation>
    <investigator_full_name>Ibrahim Elkhatib</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>infertility</keyword>
  <keyword>ivf</keyword>
  <keyword>embryo</keyword>
  <keyword>embryoscope</keyword>
  <keyword>culture media</keyword>
  <keyword>aneuploidy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

